Nintedanib Impurity 88 | CAS 1438271-13-6 - Request Quote
Nintedanib Impurity 88
| SZ CAT No: | SZ-N023120 |
| CAS No | 1438271-13-6 |
| Mol.F. | C18H15NO4 |
| Mol.Wt. | 309.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nintedanib Impurity 88 is chemically Methyl (Z)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate. Nintedanib Impurity 88 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 88 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1438271-13-6
Purchase 1438271-13-6
Order 1438271-13-6
Enquire 1438271-13-6
price of 1438271-13-6
1438271-13-6 Supplier
1438271-13-6 Manufacturer
1438271-13-6 Exporter
buy high quality Nintedanib Impurity 88
Purchase Nintedanib Impurity 88
Nintedanib Impurity 88 suppliers
Nintedanib Impurity 88 manufacturers
Nintedanib Impurity 88 price
Order Nintedanib Impurity 88
Enquire Nintedanib Impurity 88
Nintedanib Impurity 88 cost
Nintedanib Impurity 88 Supplier
Nintedanib Impurity 88 Distributor
Nintedanib Impurity 88 for Method Validation
Nintedanib Reference Standard
Nintedanib Impurity 88 for ANDA Filing
Nintedanib Impurity 88 for Forced Degradation Studies
Nintedanib Impurity 88 Identification Standards
Nintedanib Impurity 88 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.